Amgen Inc.
HIGH CONCENTRATION ANTIBODY FORMULATIONS
Last updated:
Abstract:
Discloses herein are high concentration antibody formulations comprising an anti-sclerostin immunoglobulin and an acetate salt and/or an acetate buffer and methods of use.
Status:
Application
Type:
Utility
Filling date:
21 May 2021
Issue date:
9 Sep 2021